PMCPA Case
| Case | AUTH/3447/12/20 |
| Company | Sanofi |
| Product | Dupixent (dupilumab) |
| Issue | Failure to certify a downloadable HCP website resource (Sanofi document referring to Dupixent and NICE technology appraisal guidance) |
| Channel | Company product website (www.dupixent.co.uk) – downloadable resource for health professionals |
| Applicable Code year | 2019 |
| Complaint received | 22 December 2020 |
| Case completed | 29 March 2021 |
| Appeal | No appeal |
| Breach clauses | 14.1 |
| Sanctions | Undertaking received; Additional sanctions: Not stated |
| Context | Discovered while responding to Case AUTH/3402/10/20; occurred during migration from Zinc to Veeva PromoMats |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.